Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
8737585 | Human Immunology | 2018 | 31 Pages |
Abstract
The trade-off from HLA class I expression to HLA-G expression support the immune evasion of malignant cells. The essential role of the virtually invariant HLA-G in immune tolerance, tumor immunology and its expression frequency in immune privileged tissues is known; however the specific importance of allelic subtypes in immune responses is still not well understood. HLA-Gâ01:01, â01:03 and â01:04 are the most prevalent allelic variants differing at residues 31 and 110, respectively. In cytotoxicity assays applying K562 cells transduced with the HLA-G variants as targets and NK cells as effectors the differential protective potential of HLA-G variants was analyzed. Their peptide profiles were determined utilizing soluble HLA technology. An increased protective potential of HLA-Gâ01:04 could be observed. All variants exhibit a unique peptide repertoire with marginal overlap, while Gâ01:04 differs in its peptide anchor profile substantially. The functional differences between HLA-G subtypes could be explained by the constraint of the bound peptides, modifying the pHLA-G accessible surface. For the first time a contribution of amino acid alterations within the HLA-G heavy chain for peptide selection and NK cell recognition could be observed. These results will be a step towards understanding immune tolerance and will guide towards personalized immune therapeutic strategies.
Related Topics
Life Sciences
Immunology and Microbiology
Immunology
Authors
Alexander A. Celik, Gwendolin S. Simper, Trevor Huyton, Rainer Blasczyk, Christina Bade-Döding,